SWANZA Trademark

Trademark Overview


On Monday, August 7, 2006, a trademark application was filed for SWANZA with the United States Patent and Trademark Office. The USPTO has given the SWANZA trademark a serial number of 78946349. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Thursday, June 5, 2008. This trademark is owned by Bristol-Myers Squibb Company. The SWANZA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, and pharmaceutical antibodies; syringes filled with a pharmaceutical product for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies
swanza

General Information


Serial Number78946349
Word MarkSWANZA
Filing DateMonday, August 7, 2006
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateThursday, June 5, 2008
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 11, 2007

Trademark Statements


Goods and ServicesPharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, and pharmaceutical antibodies; syringes filled with a pharmaceutical product for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 10, 2006
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10154

Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10154

Trademark Events


Event DateEvent Description
Wednesday, August 13, 2008ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Tuesday, August 12, 2008ABANDONMENT - NO USE STATEMENT FILED
Tuesday, December 4, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 11, 2007PUBLISHED FOR OPPOSITION
Wednesday, August 22, 2007NOTICE OF PUBLICATION
Friday, August 3, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, August 3, 2007ASSIGNED TO LIE
Wednesday, June 20, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 19, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 19, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 19, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 3, 2007NON-FINAL ACTION MAILED
Sunday, December 31, 2006NON-FINAL ACTION WRITTEN
Saturday, December 30, 2006ASSIGNED TO EXAMINER
Saturday, December 30, 2006ASSIGNED TO EXAMINER
Thursday, August 10, 2006NEW APPLICATION ENTERED IN TRAM